This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Research
Latest papers
The role of mutant p53R175H in de novo activation of von Willebrand factor expression in tumor cells.
Journal of thrombosis and haemostasis : JTH · 2026 · senior author
Association of Organ Preservation Methods With Von Willebrand Factor Upregulation in Microvascular Endothelial Cells Posttransplantation: Ex Vivo Lung Perfusion and Static Cold Storage.
Transplantation direct · 2026
Platelet Activation on Lung Function During Ex Vivo Lung Perfusion, Lung Transplantation, and the Role of Antiplatelet Therapy: A Narrative Review.
Transplantation direct · 2025
Latest funding
- $216,000
Cell type specificity and heterogeneity of endothelial specific gene regulation
NSERC · 2019 · Principal investigator
- $409,328
Regulation of von Willebrand factor gene expression in endothelial cells
CIHR · 2009 · Nominated PI
- $100,000
Regulation of von Willebrand factor gene expression in endothelial cells
CIHR · 2008 · Nominated PI
20 publications.
The role of mutant p53R175H in de novo activation of von Willebrand factor expression in tumor cells.
Seyyedi N, Lo CS, Alavi P, Pasdar M, Jahroudi N
Association of Organ Preservation Methods With Von Willebrand Factor Upregulation in Microvascular Endothelial Cells Posttransplantation: Ex Vivo Lung Perfusion and Static Cold Storage.
Alavi P, Himmat S, Aboelnazar NS, Buchko MT, Stewart CJ, Forgie KA, Fialka NM, Hatami S, Freed DH, Jahroudi N, Nagendran J
Platelet Activation on Lung Function During Ex Vivo Lung Perfusion, Lung Transplantation, and the Role of Antiplatelet Therapy: A Narrative Review.
El-Andari R, Kang JJH, Fialka NM, Weatherald J, Alavi P, Jahroudi N, Freed DH, Nagendran J
Hypoxia-induced TIMAP upregulation in endothelial cells and TIMAP-dependent tumor angiogenesis.
Aburahess S, Li L, Hussain A, Obeidat M, Alavi P, Azad AK, Jahroudi N, Ballermann BJ
Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants.
Lo CS, Alavi P, Bassey-Archibong B, Jahroudi N, Pasdar M
Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor.
Alavi P, Yousef Abdualla R, Brown D, Mojiri A, Nagendran J, Lewis J, Bourque SL, Jahroudi N
Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor.
Alavi P, Rathod AM, Jahroudi N
In Silico Analysis to Explore Lineage-Independent and -Dependent Transcriptional Programs Associated with the Process of Endothelial and Neural Differentiation of Human Induced Pluripotent Stem Cells.
Nakhaei-Nejad M, Trinity L, Jabbari H, Pasdar M, Jahroudi N
Regulation of von Willebrand Factor Gene in Endothelial Cells That Are Programmed to Pluripotency and Differentiated Back to Endothelial Cells.
Nakhaei-Nejad M, Farhan M, Mojiri A, Jabbari H, Murray AG, Jahroudi N
Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia.
Mojiri A, Alavi P, Lorenzana Carrillo MA, Nakhaei-Nejad M, Sergi CM, Thebaud B, Aird WC, Jahroudi N
Cell type specificity and heterogeneity of endothelial specific gene regulation
Principal investigators: Jahroudi, Nadia
Keywords: Endothelial cell heterogeneity; Endothelial cells; Gene expression; Induced pluripotent stem cells; Transcription; Transcription factor
Regulation of von Willebrand factor gene expression in endothelial cells
Principal investigators: Jahroudi, Nadia
Keywords: Endothelial Cells; Promoter Analysis; Transcription Factor; Transgenic Mice; Vascular Dysfunction; Von Willebrand Factor
Regulation of von Willebrand factor gene expression in endothelial cells
Principal investigators: Jahroudi, Nadia
Keywords: Endothelial Cells; Promoter Analysis; Transcription Factor; Transgenic Mice; Vascular Dysfunction; Von Willebrand Factor
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Paul Jurasz and Nadia Jahroudi: 2 shared papers
- Roseline Godbout and Paul Jurasz: 1 shared paper
- Roseline Godbout and Nadia Jahroudi: 1 shared paper
- Evangelos Michelakis and Paul Jurasz: 1 shared paper
- Evangelos Michelakis and Nadia Jahroudi: 1 shared paper
- Bernard Thébaud and Nadia Jahroudi: 1 shared paper
- John Lewis and Nadia Jahroudi: 1 shared paper
- Jason Weatherald and Nadia Jahroudi: 1 shared paper
- Fabrizio Giuliani and Nadia Jahroudi: 1 shared paper
- Hosna Jabbari and Nadia Jahroudi: 1 shared paper
- Medicine
- Pediatrics
- Medicine/Neurology
- Biomedical Engineering
- Physical Therapy
- Experimental Oncology
- Oncology
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Paul Jurasz
Faculty
2 shared papers, latest 2017
Evangelos Michelakis
Medicine
1 shared papers, latest 2013
Bernard Thébaud
Pediatrics
1 shared papers, latest 2019
John Lewis
Experimental Oncology
1 shared papers, latest 2023
Jason Weatherald
Physical Therapy
1 shared papers, latest 2025
Fabrizio Giuliani
Medicine/Neurology
1 shared papers, latest 2015
Roseline Godbout
Oncology
1 shared papers, latest 2017
Hosna Jabbari
Biomedical Engineering
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.